Abstract
The need for reliable epidemiological data on HIV seropositivity rates in a general population appears to conflict with the ethical requirement that consent be obtained from persons whose blood is screened for HIV antibodies. Gillet contends that informed consent is not necessary for epidemiological screening since there is no reason to link blood samples and test results with identifiable individuals. He argues that it is ethical to test blood drawn from hospital patients who have given a very general and "non-informative sort of consent" that their blood can be used anonymously for research. Even this degree of consent may be unnecessary since it would be impossible to trace an HIV positive anonymous blood sample to its source. Gillet also argues that this method of obtaining samples relieves epidemiologists of the obligation to notify individuals whose blood tests positive for HIV.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
